Integra Lifesciences Holdings (IART) EBITDA Margin (2009 - 2026)
Integra Lifesciences Holdings (IART) posted EBITDA Margin of 4.61% for Q2 2026, up 57.36% sequentially from 2.93% in Q1 2026, and up 12796.0% YoY from N/an in Q2 2025.
Integra Lifesciences Holdings (IART) EBITDA Margin (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported EBITDA Margin for 18 years, with the latest figure at 4.61% in Q2 2026.
- Quarterly EBITDA Margin rose 12796.0% year-over-year to 4.61% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 3.98% (up 3485.0% YoY) and the FY2025 annual result came in at 30.17%, down 3194.0% from the prior year.
- EBITDA Margin advanced to 4.61% in Q2 2026 per IART's latest filing, from 2.93% in the prior quarter.
- Over five years, EBITDA Margin peaked at 17.04% in Q4 2022 and troughed at 123.36% in Q2 2025.
- A 5-year average of 0.85% and a median of 4.95% in 2025 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2025 and 2026: EBITDA Margin plunged 12263 bps in 2025, then surged 12796 bps in 2026.
- Over 5 years, EBITDA Margin stood at 17.04% in 2022, then plunged by 47 bps to 9.08% in 2023, then retreated by 11 bps to 8.05% in 2024, then slumped by 34 bps to 5.3% in 2025, then decreased by 13 bps to 4.61% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 4.61%, 2.93%, and 5.3% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 19.15% |
| 10 | Integra Lifesciences Holdings | 1.32 Bn | 1.05 Bn | 219.74 Mn | 4.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.61% |
| Mar 31, 2026 | 2.93% |
| Dec 31, 2025 | 5.30% |
| Sep 30, 2025 | 2.93% |
| Jun 30, 2025 | -123.36% |
| Mar 31, 2025 | -4.05% |
| Dec 31, 2024 | 8.05% |
| Sep 30, 2024 | -2.14% |
| Jun 30, 2024 | -0.72% |
| Mar 31, 2024 | 1.07% |
| Dec 31, 2023 | 9.08% |
| Sep 30, 2023 | 6.95% |
| Jun 30, 2023 | 3.28% |
| Mar 31, 2023 | 9.55% |
| Dec 31, 2022 | 17.04% |
| Sep 30, 2022 | 16.89% |
| Jun 30, 2022 | 15.05% |
| Mar 31, 2022 | 12.26% |
| Dec 31, 2021 | 14.36% |
| Sep 30, 2021 | 14.59% |